Alle Storys
Folgen
Keine Story von antwerpes AG mehr verpassen.

antwerpes AG

euro adhoc: DocCheck AG
quarterly or semiannual financial statement
Portal business is clearly increasing

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
9-month report
07.11.2007
Cologne, 7 November 2007 - DocCheck AG, Cologne, (ISIN DE0005471007 
// Symbol 547100) increased sales by nine per cent in the first nine 
months of 2007, taking the figure from 9.4 million euro to 10.3 
million euro. The development of the portal business under 
www.doccheck.com was particularly dynamic. The largest portal for 
medical professionals in Europe increased sales by 49 per cent in the
first nine months, taking the figure from 1.6 million euro to 2.4 
million euro. In the third quarter of 2007 sales in the DocCheck 
Division increased by 77 per cent when compared to the same quarter 
in the previous year, taking the figure to 845 keuro. Sales were 
boosted in particular by an increased demand for advertising spaces 
and online direct marketing.
DocCheckShop, the trading business of DocCheck, increased sales by 24
per cent, taking the figure to 3.7 million euro. The antwerpes 
Division - the Group's agency business - recorded a slight decrease 
in sales of seven per cent in the first nine months, with the figure 
dropping to 4.5 million euro. Sales in the agency business totalled 
1.6 million euro in the third quarter which reflected a 23 per cent 
increase when compared to the second quarter. The temporary weakness 
in demand, which was caused by the healthcare reform at the beginning
of the second quarter, has therefore been overcome.
In the third quarter the operating result totalled 105 keuro 
(previous year: 201 keuro). Profit per share was 4 cent (previous 
year: 3 cent). For the first nine months EBIT totalled 38 keuro 
(previous year: 616 keuro) and profit per share totalled 5 cent 
(previous year: 10 cent). Liquid funds and current-asset securities 
totalled 14.3 million euro at the end of the third quarter. In 
addition the company holds 232,522 of its own shares as at 30 
September 2007. DocCheck AG is expecting an increase in sales 
totalling 14.2 - 14.5 million euro for the whole year, which reflects
a rise of 4.4 - 4.6 per cent, and a profit per share of 7 - 8 cent 
(previous year: 16 cent).
end of announcement                               euro adhoc 07.11.2007 08:33:47

Further inquiry note:

Tanja Mumme
+49 (0)221 92053 139
tanja.mumme@doccheck.com

Branche: Computing & Information Technology
ISIN: DE0005471007
WKN: 547100
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade

Weitere Storys: antwerpes AG
Weitere Storys: antwerpes AG